https://wikem.org/w/index.php?action=history&feed=atom&title=Mefloquine 2026-04-19T10:38:01Z Revision history for this page on the wiki MediaWiki 1.38.2 https://wikem.org/w/index.php?title=Mefloquine&diff=229500&oldid=prev 2019-09-22T23:10:01Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 23:10, 22 September 2019</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td> <td colspan="2" class="diff-lineno">Line 1:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Administration==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Administration==</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*Type: Antimalarial</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*Type: <ins style="font-weight: bold; text-decoration: none;">[[</ins>Antimalarial<ins style="font-weight: bold; text-decoration: none;">]]</ins></div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Dosage Forms:</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Dosage Forms:</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Routes of Administration: Oral</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Routes of Administration: Oral</div></td></tr> <tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l56">Line 56:</td> <td colspan="2" class="diff-lineno">Line 56:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==References==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==References==</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&lt;references/&gt;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&lt;references/&gt;</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Pharmacology]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Pharmacology<ins style="font-weight: bold; text-decoration: none;">]] [[Category:ID</ins>]]</div></td></tr> </table>

ClaireLewis https://wikem.org/w/index.php?title=Mefloquine&diff=137722&oldid=prev 2017-05-30T23:03:59Z

<p>Text replacement - &quot;OR&quot; to &quot;&#039;&#039;&#039;OR&#039;&#039;&#039;&quot;</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 23:03, 30 May 2017</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Adult Dosing==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Adult Dosing==</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*Malaria (falciparum or vivax) treatment: 750 mg PO, then 500 mg PO 6-12h later OR single dose of 1250mg PO</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*Malaria (falciparum or vivax) treatment: 750 mg PO, then 500 mg PO 6-12h later <ins style="font-weight: bold; text-decoration: none;">'''</ins>OR<ins style="font-weight: bold; text-decoration: none;">''' </ins>single dose of 1250mg PO</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>**Give with primaquine if treating p. vivax or p. ovale</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>**Give with primaquine if treating p. vivax or p. ovale</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Malaria (falciparum or vivax) prophylaxis: 250 mg weekly starting 2 weeks prior to travel to endemic area, continue 4 weeks after leaving</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Malaria (falciparum or vivax) prophylaxis: 250 mg weekly starting 2 weeks prior to travel to endemic area, continue 4 weeks after leaving</div></td></tr> </table>

Mholtz https://wikem.org/w/index.php?title=Mefloquine&diff=106935&oldid=prev 2016-10-19T17:35:58Z

<p>Created page with &quot;==Administration== *Type: Antimalarial *Dosage Forms: *Routes of Administration: Oral *Common Trade Names: ==Adult Dosing== *Malaria (falciparum or vivax) treatment: 750 mg...&quot;</p> <p><b>New page</b></p><div>==Administration==<br /> *Type: Antimalarial<br /> *Dosage Forms:<br /> *Routes of Administration: Oral<br /> *Common Trade Names: <br /> <br /> ==Adult Dosing==<br /> *Malaria (falciparum or vivax) treatment: 750 mg PO, then 500 mg PO 6-12h later OR single dose of 1250mg PO<br /> **Give with primaquine if treating p. vivax or p. ovale<br /> *Malaria (falciparum or vivax) prophylaxis: 250 mg weekly starting 2 weeks prior to travel to endemic area, continue 4 weeks after leaving<br /> <br /> ==Pediatric Dosing==<br /> ''Safety/efficacy not established in patients &lt;6mo, limited experience treating patients &lt;20kg''<br /> *Malaria (falciparum or vivax) treatment: 15 mg/kg PO, then 10 mg/kg PO 6-12h after initial dose (max total dose: 1250 mg)<br /> **Give with primaquine if treating p. vivax or p. ovale<br /> *Malaria (falciparum or vivax) prophylaxis: <br /> **&lt;45kg: 5 mg/kg PO weekly (&lt;45kg)<br /> **&gt;45kg: 250 mg PO weekly<br /> **Start 2 weeks prior to travel to endemic area, continue 4 weeks after leaving<br /> <br /> ==Special Populations==<br /> *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: B<br /> *[[Lactation risk categories|Lactation risk]]: Infant risk cannot be ruled out<br /> *Renal dosing: <br /> *Hepatic dosing: <br /> <br /> ==Contraindications==<br /> *Allergy to class/drug<br /> *Use for malaria prophylaxis in patients with active or recent history of severe depression, anxiety, or psychotic disorders<br /> *Use for malaria prophylaxis in patients with history of seizures<br /> <br /> ==Adverse Reactions==<br /> ===Serious===<br /> *Seizures<br /> *Prolonged QT<br /> *Increased risk of suicide<br /> *Pneumonitis<br /> ===Common===<br /> *Weird dreams<br /> *Dizziness, headache, coordination problems<br /> *Somnolence, insomnia, anxiety<br /> *Nausea/vomiting, diarrhea, abdominal pain<br /> <br /> ==Pharmacology==<br /> *Half-life: 2-4 weeks<br /> *Metabolism: <br /> *Excretion: Mostly fecal<br /> <br /> ==Mechanism of Action==<br /> *Plasmodium schizonticide, acts in erythrocytic stages of plasmodium species<br /> <br /> ==Comments==<br /> <br /> ==See Also==<br /> *[[Malaria]]<br /> ==References==<br /> &lt;references/&gt;<br /> [[Category:Pharmacology]]</div>

ClaireLewis